Page last updated: 2024-10-20

tryptamine and Hepatitis B Virus Infection

tryptamine has been researched along with Hepatitis B Virus Infection in 1 studies

Research Excerpts

ExcerptRelevanceReference
"A series of tryptamine derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in the HepG2."7.77Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus. ( Duan, WH; Qu, SJ; Tan, CH; Wang, GF; Yao, SY; Zhu, DY; Zuo, JP, 2011)
"A series of tryptamine derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in the HepG2."3.77Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus. ( Duan, WH; Qu, SJ; Tan, CH; Wang, GF; Yao, SY; Zhu, DY; Zuo, JP, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qu, SJ1
Wang, GF1
Duan, WH1
Yao, SY1
Zuo, JP1
Tan, CH1
Zhu, DY1

Other Studies

1 other study available for tryptamine and Hepatitis B Virus Infection

ArticleYear
Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
    Bioorganic & medicinal chemistry, 2011, May-15, Volume: 19, Issue:10

    Topics: Antiviral Agents; Cell Survival; DNA, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; S

2011